ALMR - Company ID 0002104204
The table below shows Alamar Biosciences, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $33.55M | $29.43M | $26.04M | $19.91M | $16.16M | $13.09M |
| Cost of revenue | $12.90M | $11.71M | $11.58M | $8.02M | $7.58M | $6.70M |
| Gross profit | $20.64M | $17.72M | $14.46M | $11.90M | $8.58M | $6.39M |
| R&D | $16.17M | $13.82M | $13.02M | $10.21M | $8.89M | $8.30M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $19.62M | $17.43M | $13.79M | $9.58M | $7.61M | $6.64M |
| Operating income | -$15.14M | -$13.53M | -$12.35M | -$7.88M | -$7.92M | -$8.55M |
| Income tax | $94.00K | -$93.00K | $464.00K | $440.00K | - | - |
| Net income | -$13.34M | -$13.20M | -$21.32M | -$8.00M | -$7.02M | -$7.66M |
| EPS (diluted) | -$0.19 | -$0.22 | -$1.74 | -$0.69 | -$0.62 | -$0.68 |